Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Noramco
Noramco
Activities:
Manufacturing
Ingredients
X
LinkedIn
Trending Articles
OINDPs: Nosey about recent developments?
OINDPs are a user friendly and efficacious alternative to injectables in several disease areas
Transforming healthcare with patient centricity
In this opinion article, John Kytariolos, Head of Clinical and Scientific Affairs at Adragos Pharma, discusses patient-centric dosage forms, their properties and the impact...
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Compact process thermostat for efficient temperature control in the laboratory
The temperature control system is designed for the accurate temperature control of small research reactors between -40 to +200 °C
AviadoBio expands presence at Canary Wharf
The company has acquired 11,000 sqft of laboratory and office space in Canary Wharf to accommodate the growing team
Upcoming event
Making Pharmaceuticals
23–24 April 2024 | Exhibition | Coventry, UK
See all
Related Content
Noramco announces strategic alignment with Purisys and Halo Pharma
The three organisations will provide North American supply chain solutions for clinical and commercial APIs and drug products
Manufacturing
Nemus finds US supplier for CBD-based retinal disease therapy
Controlled substance producer Noramco has been chosen to produce and scale up the new treatment
Ingredients
Noramco announces provisional patent application of proprietary cannabidiol (CBD)
Filing with the US Patent and Trademark Office covers pure cannabidiol compositions
Manufacturing
Development of patient friendly formulations agreement signed
Noramco and SPI Pharma have signed an agreement to develop and license a set of value-added formulation packages for global pharmaceutical manufacturers of finished dosage forms
Ingredients
Business going forward for Normaco
Noramco, a global leader in the manufacture and supply of controlled substance active pharmaceutical ingredients announces major developments in its pharmaceutical offering at this year’s CPhI Worldwide
Ingredients
Noramco planning expansion in API market
Noramco will outline its business expansion plan at the Drug, Chemical and Associated Technologies Association (DCAT) meeting
Manufacturing
Aesica forms alliance with Noramco
For the manufacture of codeine
Subscribe now